Completed from United States
The Farmacovigilância course at Stanmore School of Business exceeded my expectations. The curriculum was perfectly aligned with my goal of mastering adverse‑event reporting, and the modules on signal detection gave me hands‑on experience with real‑world datasets. I especially appreciated the downloadable SOP templates, which I’ve already integrated into my work at a pharmaceutical firm. The instructors explained regulatory nuances in a clear, professional manner, and the case‑study workshops helped me develop a complete risk‑management plan for a new oncology drug. Overall, the course material was high‑quality, up‑to‑date, and directly applicable to my daily responsibilities.
Fiz o curso Farmacovigilância da Stanmore School of Business e adorei! O conteúdo era bem focado nas minhas metas de aprender a registrar e analisar eventos adversos. O módulo prático sobre uso da ferramenta VigiBase foi muito útil – já usei nas minhas análises na empresa. Os materiais de apoio, como os guias de boas práticas da OMS, eram atuais e fáceis de entender. O professor explicou tudo de forma descontraída, o que tornou o aprendizado bem leve. Saí do curso confiante para criar um plano de monitoramento de segurança para um novo medicamento.
Wow! The Farmacovigilância program at Stanmore School of Business was absolutely brilliant. I signed up to improve my knowledge of EU pharmacovigilance regulations, and the course delivered exactly that and more. The interactive simulations on data entry into EudraVigilance were a game‑changer – I can now process reports in half the time. The lecture on causality assessment gave me a solid framework that I’ve already applied to a recent safety signal. The quality of the slide decks and supplemental readings was top‑notch, and the community forum let me exchange ideas with peers worldwide. I left feeling energized and fully equipped for my new role.
The Farmacovigilância course offered by Stanmore School of Business provided a very detailed and structured learning path. My aim was to understand the end‑to‑end process of drug safety monitoring, and the syllabus covered everything from case intake to signal evaluation. The practical exercises on creating Individual Case Safety Reports (ICSRs) were especially helpful; I practiced using the ICH E2B format and now feel comfortable preparing reports for my regulatory submissions. The course materials, including the latest ICH guidelines PDFs, were comprehensive and well‑organized. Although the pacing was intense, the depth of information gave me a solid foundation and I am now confident in handling pharmacovigilance tasks at my organization.
